“…Similarly, mGluRs act as a second messenger in the signalling pathway that modulates synaptic transmission and neuronal excitability, suggesting a potential therapeutic utility in AD, Parkinson disease, schizophrenia, anxiety and depression [65,66]. Consequently, further research into these components may prove to be potential opportunities for treatment for Huntington's disease, AD, epilepsy, and trauma [67,68].…”